Some features of Rosiglitazone hydrochloride

This rosiglitazone hydrochloride and sulfonylurea or metformin can significantly enhance share, fall blood sugar role; With insulin, can improve blood sugar control share of instability, and can reduce the dosage of insulin (the daily can reduce 4.8 ~ 9.4 units). This rosiglitazone hydrochloride a day of 2 ~ 8 mg, share or don't share sulfonylurea or metformin treatment after 26 weeks, insulin resistance by 3 ~ 25%, about improving islet beta-nearly 94% cell functions, and use sulfonylurea and placebo all can make insulin resistance, increase with metformin, no any change. Have not yet found significant liver, kidney toxicity, by the doctors and patients welcome.. Development of hydrochloric acid rosiglitazone and Malay acid rosiglitazone rosiglitazone is different, the former of water soluble salts than the latter, be beneficial to human body to absorb. This rosiglitazone hydrochloride is a potential market and a good development prospect of the new Ⅱ diabetes drug use
http://www.lookchem.com/Rosiglitazone-hydrochloride/